<DOC>
	<DOCNO>NCT00086242</DOCNO>
	<brief_summary>RATIONALE : Telephone counsel treatment may reduce stress improve well-being quality life patient cervical cancer . Changes quality life may relate change immune function neuroendocrine function . PURPOSE : This randomized phase I trial study well telephone counsel work compare standard care reduce stress patient complete treatment stage I , stage II , stage III cervical cancer .</brief_summary>
	<brief_title>Telephone Counseling Standard Care Patients Who Have Completed Treatment Stage I , Stage II , Stage III Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare quality life ( QOL ) baseline change QOL , immune response , neuroendocrine parameter time patient complete treatment stage I-III cervical cancer receive psychosocial telephone counsel v usual care . - Correlate psychosocial measure immunologic stance . OUTLINE : This randomize , control , parallel-group study . Patients randomize 1 2 intervention arm . - Arm I : Patients undergo psychosocial telephone counsel comprise 5 weekly session 1-month follow-up session learn strategy reduce stress . - Arm II : Patients undergo usual care approximately 4 month . All patient complete questionnaire Quality life assessment baseline 4 month . They also undergo saliva blood sample collection baseline 4 month neuroimmune study . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cervical cancer past 315 month Stage IIII disease Completed therapy cervical cancer â‰¥ 1 month ago Not receive ongoing treatment PATIENT CHARACTERISTICS : Resident Orange , San Diego , Imperial County California English Spanish speak No serious acute chronic illness Has access telephone PRIOR CONCURRENT THERAPY : See Disease Characteristics More 4 week since prior immunotherapy More 30 day since prior investigational drug No prior biological response modifier No concurrent corticosteroids No concurrent immunosuppressive therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>stage IA cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
</DOC>